Home›Vortioxetine

Vortioxetine

Also known as: Trintellix

Route: Oral

Check Vortioxetine Interactions →
22 interactions on record⛔ Black Box Warning

Vortioxetine has 22 known drug interactions based on U.S. FDA drug labeling data. Of these, 6 are contraindicated combinations that should be avoided entirely. Notable interactions include combinations with Isocarboxazid, Linezolid, Methylene Blue. Patients taking Vortioxetine should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.

Total
22
Contraindicated
6
Moderate
15

Contraindicated (6)

  • Vortioxetine + Isocarboxazid— Concomitant use with MAOIs increases risk of serotonin syndrome. Contraindicated with MAOI or within 14 days of stopping…
  • Vortioxetine + Linezolid— Concomitant use increases risk of serotonin syndrome. Contraindicated with linezolid or within 21 days of stopping vorti…
  • Vortioxetine + Methylene Blue— Concomitant intravenous use increases risk of serotonin syndrome. Contraindicated with IV methylene blue or within 21 da…
  • Vortioxetine + Phenelzine— Concomitant use with MAOIs increases risk of serotonin syndrome. Contraindicated with MAOI or within 14 days of stopping…
  • Vortioxetine + Selegiline— Concomitant use with MAOIs increases risk of serotonin syndrome. Contraindicated with MAOI or within 14 days of stopping…
  • Vortioxetine + Tranylcypromine— Concomitant use with MAOIs increases risk of serotonin syndrome. Contraindicated with MAOI or within 14 days of stopping…

Moderate (15)

  • Vortioxetine + Amphetamine— Serotonergic drugs that increase risk of serotonin syndrome when used with TRINTELLIX. Monitor for serotonin syndrome sy…
  • Vortioxetine + Aspirin— Antiplatelet agent may potentiate risk of bleeding when used with vortioxetine. Monitor patients for increased bleeding …
  • Vortioxetine + Bupropion— Strong CYP2D6 inhibitor increases plasma concentrations of vortioxetine. Reduce TRINTELLIX dose by half when coadministe…
  • Vortioxetine + Buspirone— Serotonergic drug that increases risk of serotonin syndrome when used with TRINTELLIX. Monitor for serotonin syndrome sy…
  • Vortioxetine + Carbamazepine— Strong CYP inducer decreases plasma concentrations of vortioxetine. Consider increasing TRINTELLIX dose; maximum dose no…
  • Vortioxetine + Fluoxetine— Strong CYP2D6 inhibitor increases plasma concentrations of vortioxetine. Reduce TRINTELLIX dose by half when coadministe…
  • Vortioxetine + Lithium— Serotonergic drug that increases risk of serotonin syndrome when used with TRINTELLIX. Monitor for serotonin syndrome sy…
  • Vortioxetine + Paroxetine— Strong CYP2D6 inhibitor increases plasma concentrations of vortioxetine. Reduce TRINTELLIX dose by half when coadministe…
  • Vortioxetine + Phenytoin— Strong CYP inducer decreases plasma concentrations of vortioxetine. Consider increasing TRINTELLIX dose; maximum dose no…
  • Vortioxetine + Quinidine— Strong CYP2D6 inhibitor increases plasma concentrations of vortioxetine. Reduce TRINTELLIX dose by half when coadministe…
  • Vortioxetine + Rifampin— Strong CYP inducer decreases plasma concentrations of vortioxetine. Consider increasing TRINTELLIX dose; maximum dose no…
  • Vortioxetine + St. John'S Wort— Serotonergic drug that increases risk of serotonin syndrome when used with TRINTELLIX. Monitor for serotonin syndrome sy…
  • Vortioxetine + Triptans— Serotonergic drugs that increase risk of serotonin syndrome when used with TRINTELLIX. Monitor for serotonin syndrome sy…
  • Vortioxetine + Tryptophan— Serotonergic drug that increases risk of serotonin syndrome when used with TRINTELLIX. Monitor for serotonin syndrome sy…
  • Vortioxetine + Warfarin— Anticoagulant may potentiate risk of bleeding with vortioxetine. Carefully monitor international normalized ratio.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.

CDI: source-linked explanations